Stifel Nicolaus analyst James Condulis maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $80.00. The company’s shares closed yesterday at $47.45.
Stifel Nicolaus analyst Adam Borg maintained a Buy rating on Autodesk (ADSK – Research Report) today and set a price target of $350.00. The company’s shares closed yesterday at $282.35.
Investing.com -- Stifel downgraded Vertex (NASDAQ:VRTX), Inc to “Hold” from “Buy” and lowered its price target to $31 from $35, over the company’s investment strategy and valuation.
Stifel's broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe, Bruyette & ...
TFI International (NYSE:TFII – Free Report) had its price objective decreased by Stifel Nicolaus from $147.00 ... Public Employees Retirement System of Ohio acquired a new stake in shares ...
Insulet (NASDAQ:PODD – Get Free Report) had its price target hoisted by equities research analysts at Stifel Nicolaus from $245.00 to $293.00 in a research note issued on Friday,Benzinga reports.
Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire & Co., LLC business divisions ...
What should I know about this firm? Stifel, Nicolaus & Co. Inc. offers investment advising services that let individuals choose the level of control they have over their portfolio. Everyday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results